The clinical significance of non‐HLA antibodies on renal allograft survival is a matter of
debate, due to differences in reported results and lack of large‐scale studies incorporating …

Whereas regular allocation avoids unacceptable mismatches on the donor organ, allocation
to highly sensitized patients within the Eurotransplant Acceptable Mismatch (AM) program is …

Background. There is no consensus in the literature on the interpretation of single-antigen
bead positive for a specific HLA antibody. Methods. To inform the debate, we studied the …

The best treatment for patients with end-stage renal disease is kidney transplantation.
Although graft survival rates have improved in the last decades, patients still may lose their …

Background Complement-fixing antibodies against donor HLA are considered a
contraindication for kidney transplant. A modification of the IgG single-antigen bead (SAB) …

Background Maintaining anonymity is a requirement in the Netherlands and Sweden for
kidney donation from live donors in the context of nondirected (or unspecified) and paired …

Background Previous studies have indicated decreased health-related quality of life
(HRQoL) shortly after kidney donation, returning to baseline in the longer term. However, a …

Context Wound morbidity is an important surgical complication after kidney transplant.
Objective To assess risk factors for postoperative wound complications and the impact of …

Polyomavirus BK (BKPyV) frequently reactivates in immunosuppressed renal transplant
recipients (RTRs) and may lead to graft loss due to BKPyV-induced interstitial nephritis …

Anonymity between living donors and recipients is a topic of discussion among transplant
professionals. This longitudinal study explored living kidney donors' and patients' …